BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16398617)

  • 21. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis.
    Pufe T; Petersen W; Tillmann B; Mentlein R
    J Rheumatol; 2001 Jul; 28(7):1482-5. PubMed ID: 11469450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy.
    Otani N; Minami S; Yamoto M; Shikone T; Otani H; Nishiyama R; Otani T; Nakano R
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3845-51. PubMed ID: 10523040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas.
    Poulaki V; Mitsiades CS; McMullan C; Sykoutri D; Fanourakis G; Kotoula V; Tseleni-Balafouta S; Koutras DA; Mitsiades N
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5392-8. PubMed ID: 14602779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells.
    Murata M; Kador PF; Sato S
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A; Dunk C; Kniss D; Wilkes M
    Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
    He Y; Smith SK; Day KA; Clark DE; Licence DR; Charnock-Jones DS
    Mol Endocrinol; 1999 Apr; 13(4):537-45. PubMed ID: 10194760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV; Brace RA; Cheung CY
    Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor (VEGF) and its receptors.
    Neufeld G; Cohen T; Gengrinovitch S; Poltorak Z
    FASEB J; 1999 Jan; 13(1):9-22. PubMed ID: 9872925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans.
    Kazemi M; Carrer A; Moimas S; Zandonà L; Bussani R; Casagranda B; Palmisano S; Prelazzi P; Giacca M; Zentilin L; De Manzini N; Giacca M; Zacchigna S
    Cancer Gene Ther; 2016 May; 23(5):125-32. PubMed ID: 27033458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
    Stevens M; Oltean S
    Cells; 2019 Mar; 8(4):. PubMed ID: 30925751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.